ArticleInfection and drug resistance2019

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy.

Umberto Restelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.